LA SORVEGLIANZA DEI SOGGETTI AD ALTO RISCHIO PORTA ALLA IDENTIFICAZIONE PRECOCE DEL CANCRO DEL PANCREAS! UN GRANDE STUDIO MULTICENTRICO ITALIANO SU 524 PAZIENTI. DA” Am J Gastroenterol”

Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer Salvatore Paiella, Gabriele Capurso et al. Abstract Introduction: Pancreatic cancer (PC) surveillance of high-risk individuals (HRI) is becoming more common worldwide, aiming at anticipating PC diagnosis at a pre-clinical stage. In 2015 the Italian Registry of Families at Risk of Pancreatic Cancer (IRFARPC) was…

BREAKING NEWS : ASPIRINA MIGLIORA LA NASH IN UN TRIAL AMERICANO RANDOMIZZATO VS PLACEBO! DA “AASLD LIVER MEETING NOVEMBRE 2023”

  DAILY ASPIRIN THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL Robert M. Wilechansky et al. Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic, progressive disease with substantial morbidity and mortality and no approved treatments. Observational studies have linked aspirin use to reduced prevalence and progression of MASLD.…

“GASTRIC OUTLET” OBSTRUCTION: MEGLIO LA GASTROENTEROANASTOMOSI VIA ECOENDO VS LA PROTESI METALLICA DUODENALE ! UN GRANDE TRIAL MULTICENTRICO RANDOMIZZATO. DA” LANCET GASTROENTEROLOGY & HEPATOLOGY”

Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial Prof Anthony Yuen Bun Teoh et al. Summary Background Endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) is a novel endoscopic method to palliate malignant gastric outlet obstruction. We aimed to assess whether the use of EUS-GE with a…

MALATTIA DI CROHN. LA COMPOSIZIONE DEL MICROBIOMA ANNUNCIA LA COMPARSA DELLA MALATTIA NEI FAMILIARI! DA “GASTROENTEROLOGY! (FREE)

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives Juan Antonio Raygoza Gara et al. Background & Aims The cause of Crohn’s disease (CD) is unknown, but the current hypothesis is that microbial or environmental factors induce gut inflammation in genetically susceptible individuals, leading to chronic intestinal inflammation. Case-control…